Scott Wolchko - President and CEO, Fate Therapeutics Inc

As of November 22, 2021


Scott Wolchko Net Worth

  • Net worth is estimated to be at least $71.98M
  • Owns at least 480,268 units of Fate Therapeutics Inc stock
  • Sold an estimated value of $42.49M in the last 7 years at Fate Therapeutics Inc

Scott Wolchko Compensation at Fate Therapeutics Inc in 2020

  • Earned a $570,000 salary
  • Rewarded $1,451,340 in stock value and options
  • Received a total compensation of $5,600,167

Scott Wolchko Trading

  • Largest purchase of shares was 60,000 units , worth over $253.91K on November 16, 2020
  • Largest sale of shares was 69,407 units , worth over $8.07M on January 12, 2021
  • In total has made about 33 transactions over 7 years
  • Usually trades in January, with the busiest year in 2021
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Scott Wolchko Mailing Address

  • Mailing address is C/o Fate Therapeutics, Inc. 3535 General Atomics Court, Suite 200 San Diego CA 92121 CA

Fate Therapeutics Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
J. Scott Wolchko 2020 $570,000 - $1,451,340 $3,222,577 $356,250 - $5,600,167
J. Scott Wolchko 2019 $540,000 - $4,137,500 $5,732,955 $310,500 - $10,720,955
J. Scott Wolchko 2018 $516,000 - - $2,756,998 $258,000 - $3,530,998
Edward J. Dulac III 2020 $142,500 $137,917 $1,420,800 $3,786,529 $75,833 $120,000 $5,683,579
Bahram Valamehr, Ph.D. 2020 $390,000 - $549,750 $1,324,347 $195,000 - $2,459,097
Bahram Valamehr, Ph.D. 2019 $375,000 - $744,750 $1,547,898 $150,938 - $2,818,586
Bahram Valamehr, Ph.D. 2018 $321,865 - - $2,138,235 $117,250 - $2,577,350
Cindy R. Tahl, J.D. 2020 $390,000 - $549,750 $1,324,347 $195,000 - $2,459,097
Cindy R. Tahl, J.D. 2019 $375,000 - $744,750 $1,547,898 $150,938 - $2,818,586
Cindy R. Tahl, J.D. 2018 $350,000 - - $906,465 $122,500 - $1,378,965
Daniel D. Shoemaker, Ph.D. 2020 $390,000 - $549,750 $1,324,347 $195,000 - $2,459,097
Daniel D. Shoemaker, Ph.D. 2019 $375,000 - $744,750 $1,547,898 $150,938 - $2,818,586
Daniel D. Shoemaker, Ph.D. 2018 $365,000 - - $842,338 $127,750 - $1,335,088
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1434316/000119312521124699/d85377ddef14a.htm

Fate Therapeutics Inc Insider Trading

  • The most recent transaction was 20,000 units sold on November 22, 2021 by Scott Wolchko worth over $1.09M
  • In the last 8 years, insiders at Fate Therapeutics Inc sold an estimated value of $108.45M and bought an estimated value of $169.07M
  • The most active traders are Scott Wolchko, President and CEO,  Amir Nashat, Director,  and Cindy Tahl, General Counsel and Secretary
  • Insider trading is most common in January, with the busiest year in 2021

FATE THERAPEUTICS INC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1